CYBIN INC. — Form SCHEDULE 13D
Filed September 9, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 18/100
What the filing says
Paul Glavine filed a Schedule 13D with the SEC on September 9, 2026, disclosing an acquisition of beneficial ownership in Cybin Inc. (CIK 0001833141), a pharmaceutical preparations company incorporated in Ontario, Canada. The filing document itself does not display the specific share count, percentage of ownership acquired, purchase price, or date of acquisition in the text provided—only the filing date and filer identity are confirmed.
Why this rating
Schedule 13D is routine disclosure; no ownership %, share count, or transaction dollar amount visible in text. Cannot assess materiality without those specifics.
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.